title: FDA post-approval expectations for adventitious virus contamination prevention.
abstract: CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA).
authors.affiliation: Office of Manufacturing and Product Quality, Office of Compliance, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Richard L
authors.initials: RL
authors.lastname: Friedman
mesh_terms: D001688:Biological Products; D004340:Drug Contamination; D006801:Humans; D011322:Primary Prevention; D012495:San Francisco; D014780:Viruses
chemical_list: D001688:Biological Products